Stunting and Targeting Reduction of Impaired Growth in Kids Effectively

Household Component Inclusion * Children aged 1-5 years experiencing stunting or its risk (defined as HAZ ≤ -1 SD at baseline) * Children's legal guardian agrees to participate in the study * Full term pregnancy (defined as ≥ 37 weeks gestation and ≥ 2500g birth weight) * Residence in study area attending Children International (NGO) centers Exclusion • Children who have current medical conditions requiring hospitalization: gastrointestinal tract infections or inflammatory bowel disease; active tuberculosis; acute hepatitis B or C; human immunodeficiency virus OR malignancy; cystic fibrosis; immunodeficiency syndromes, congenital abnormalities of the respiratory tract, such as lung and respiratory cilia; an unsuspected foreign body in the respiratory tract; asthma; heart abnormalities; abdominal hernias; and known metabolic disorders, renal impairment, or rheumatic diseases and diabetes * Congenital condition * Children with disabilities such as cerebral palsy, autism spectrum disorder, neurodegenerative disorders * Children with chronic or acute infections e.g. HIV, malaria * Children who are taking medications or other agents that could potentially affect body weight, including diuretics, appetite stimulants, steroids, and growth hormones * Children who have genetic conditions impacting weight status such as but not limited to: Bardet-Biedl Syndrome, Prader-Willi Syndrome * Children already enrolled in a nutrition program that includes a supplement * Participant has an…